Abstract
Herein, we describe the preparation of 1-tetralones bearing a remote quaternary stereocenter in a highly enantioselective manner. A sequence of Pd-catalyzed asymmetric 1,4-addition and Rh-catalyzed enantiospecific C−C/C−H activation delivers diverse 1-tetralones with a C4 quaternary stereocenter, which are prepared in good overall yields and high enantioselectivity.
Keywords: C−C activation, asymmetric synthesis, quaternary stereocenter, 1-tetralone
Graphical Abstract

Summary
Here, 1-tetralones bearing a remote quaternary stereocenter can be constructed through a combination of Pd-catalyzed asymmetric conjugate addition and Rh-catalyzed enantiospecific C−C/C−H bond re-organization from readily available cyclopentenones and arylboronic acids. The transformation features the conversion of an easily-forming proximal stereocenter to a remote one, which could have broad implications on the construction of remote quaternary stereocenters.
All-carbon quaternary stereocenters commonly exist in natural products and bioactive molecules.1 The construction of all-carbon quaternary centers with control of absolute stereochemistry has been an ongoing challenge and received substantial attention from the synthetic community.2 To date, a range of catalytic methods have been developed for enantioselective formation of all-carbon quaternary centers.1,2 However, most of these approaches require the presence of an adjacent reactive functional group. For example, numerous innovative approaches have been made available to introduce quaternary centers α or β to carbonyl groups via asymmetric catalysis (Scheme 1a).3,4 On the other hand, few strategies are available to construct remote quaternary centers in an enantioselective manner due to the lack of reactive sites and controlling handles.5
Scheme 1.

(a) Common strategies for construction of quaternary all-carbon stereocenters; (b) Representative 1-tetralones with a C4 quaternary stereocenter in natural products and advanced intermediate; (c) C−C/C−H bond re-organization in 3-arylcyclopentanones; (d) This work: Construction of a remote quaternary stereocenter
On the other hand, carbon−carbon bond (C−C) activation reactions catalyzed by transition metals allow for deconstructive rearrangement of carbon skeletons, thereby enabling new strategic bond disconnections for constructing complex molecules.6,7 This inspired us to examine a distinct approach for installing remote chiral all-carbon quaternary centers, which involves first introducing the stereocenter at an adjacent position, e.g. β to carbonyl, and then transporting it to a distal position via C−C activation. In this context, 1-tetralones bearing a C4 quaternary center have been found in many bioactive compounds and often serve as important synthetic intermediates (Scheme 1b);8 however, they are nontrivial to prepare asymmetrically. Recently we developed a general and catalytic method for converting 3-arylcyclopentanones to 1-tetralones via Rh-catalyzed C−C activation followed by intramolecular C−H functionalization (Scheme 1c).9,10 In this transformation, the β stereocenter in the cyclopentanone substrate is transferred to the C4 stereocenter in the 1-tetralone product through bond re-organization. Thus, if enantioenriched cyclopentanones that contain a β quaternary stereocenter could be used as substrates, a convenient enantioselective preparation of 1-tetralones bearing a C4 quaternary center would be realized. Here, we describe the development of a catalytic C−C activation approach for constructing remote all-carbon quaternary centers in 1-tetralones (Scheme 1d).
Among various conjugate addition methods,4,11 the palladium-catalyzed 1,4-arylation, pioneered by Lu, Stoltz, Minnaard etc., excel at constructing quaternary stereocenters at ketone β-positions,12–16 which became our first choice to prepare cyclopentanones bearing a β quaternary center. While cyclohexenones have been extensively explored as substrates in these reactions, only a few examples are known for five-membered substrates, which are mainly restricted to 3-methyl-1-cyclopentenone.17 Thus, the first objective of this approach is to develop an efficient condition that can prepare 3,3-disubstituted cyclopentanones in high yields and high enantioselectivity. Towards the end, 3-ethyl-2-cyclopentenone (1a) and phenylboronic acid were chosen as the model substrates (Table 1). Under the previously reported conditions by Stoltz,13 the desired product (2a) was indeed obtained in a good level of enantiomeric ratio (er) albeit in moderate yields (entries 1 and 2). The enantioselectivity was further improved to 97.0:3.0 er by lowering the reaction temperature; however, the yield dropped significantly (entry 3). After careful examination of various reaction parameters, it was ultimately found that higher concentration was important to afford both high yield and excellent enantioselectivity, even at ambient temperature (entry 4). Finally, iterative addition of phenylboronic acid further improved reaction efficiency without compromising the er, probably through suppressing the undesired reactions such as homo-coupling (entry 5).5a,15,16b Meanwhile, the Minnaard’s conditions were also effective, affording the product in 87% yield and 96.5:3.5 er. (see supporting information, Table S2).14b
Table 1.
Optimization of conditions in the Pd-catalyzed asymmetric 1,4-addition
| ||||
|---|---|---|---|---|
| entry | conc. of 1a | temp (°C) | yield (%)a | erb |
| 1 | 0.25 M | 60 °C | 69% | 95.5:4.5 |
| 2c | 0.25 M | 40 °C | 74% | 94.5:5.5 |
| 3 | 0.25 M | rt | 53% | 97.0:3.0 |
| 4 | 0.5 M | rt | 86% | 97.0:3.0 |
| 5 d | 0.5 M | rt | 95% | 97.0:3.0 |
Isolated yield.
Determined by HPLC analysis using commercial chiral columns.
5 equiv. of H2O and 30 mol% of NH4PF6 were used as additives.
Addition of PhB(OH)2 at 3 h intervals. For details, see Supporting Information.
The conditions in entry 5 (Table 1) were employed in the synthesis of enantioenriched cyclopentanone substrates (Table 2). The scope of the asymmetric conjugate addition was first investigated using different arylboronic acids. The reaction of 1a with 4-methylphenylboronic acid gave comparable enantioselectivity to that of phenylboronic acid but with reduced yield. In general, decreased yield and enantioselectivity were observed when using substituted arylboronic acids. This issue could be partially relieved by increasing the reaction temperature to 60 °C and loading more catalyst (to 10 mol%), as illustrated in the case of 2c and 2g (for more details, see Supporting Information). Of note, this high temperature was supposed to be necessary to increase the solubility of arylboronic acid, which was often observed as an untransparent mixture at room temperature. Under the modified conditions, cyclopentanones bearing electron-rich (2c, 2d) or electro-poor aryl groups (2e-2h) could be obtained in good to excellent yields and excellent er. A wide range of functional groups on the aromatic ring were tolerated, including ether (2c), 4-chloro (2e), 4-fluoro (2f), trifluoromethyl (2g) and ester (2h). The meta-substituted arylboronic acid also proved to be a competent substrate, providing the adduct (2i) without diminishing the enantioselectivity.18 In addition, cyclopentenones bearing other β-alkyl substituents, including butyl, cyclohexyl, and an ester-substituted alkyl chain, also delivered the desired arylation products (2j-2l) in good yields and excellent er. Note that elevating the reaction temperature to 60 °C was essential for cyclopentenones possessing either a branched cyclohexyl group (2k) or an ester-substituted alkyl chain (2l).
Table 2.
Substrate preparation via the Pd-catalyzed asymmetric 1,4-addition
|
Condition: cyclopentenone substrate (0.5 mmol), arylboronic acid (1.0 mmol), Pd(TFA)2 (0.05 mmol), (S)-t-BuPyOX (0.06 mmol) in 1 mL of 1,2-dichloroethane for 24 h. All yields are isolated yields. Enantiomeric ratios were determined by HPLC analysis using commercial chiral columns.
The reaction was carried out at 60 °C.
10 mol% Pd(TFA)2 and 12 mol% (S)-t-BuPyOX were used.
These cyclopentanones with a β-quaternary stereocenter were then subjected to the Rh-catalyzed C−C/C−H re-organization reaction (Table 3). Under our previously reported conditions,9a various 1-tetralones were obtained in good yields with moderate to high regioselectivity (1-tetralone versus 1-indanone). Generally, substrates with a strong electron-donating (3c) or electron-withdrawing group (3e, 3g and 3h) showed excellent regioselectivity (>10:1, rr = major: minor) favoring the desired 1-tetralone, while substrates bearing electron-neutral aryl group (3a, 3b and 3d) delivered the product in moderate yields and moderate regioselectivity. Substitution at the meta position (3i) was also tolerated. Compared to the prior cyclopentanone substrates with a β tertiary center,9a significantly higher reactivity was observed for these with a β quaternary center as no additional 2-aminopyridine (previously 50 mol%) or higher reaction temperature (previously 150 °C) was needed for electronically or sterically biased substrates.9a The enhanced reactivity could likely be explained by the Thorpe–Ingold effect,19 where the quaternary stereocenter promotes intramolecular cyclization. In addition to the arene moiety, the effect of the β-alkyl substituents on the C−C activation reaction was also evaluated. The use of butyl (3j), cyclohexyl (3h), and 2-methoxycarbonylethyl (3k) substituents all led to higher yields than the standard ethyl substrate (3a). In particular, bulky cyclohexyl group rendered the reaction with excellent regioselectivity (3k). In all cases, the enantiomeric ratio of the quaternary stereocenters were fully retained (>99% es) to be incorporated in 1-tetralones through this transformation. Besides, the enantiomeric ratio of the minor 1-indanone product 3j’ also remained the same, as exemplified in the reaction of 2j (>99% es, see Supporting Information for details).
Table 3.
Scope of Rh-catalyzed C−C/C−H activation
|
Condition: substrates 2a-2l (0.2 mmol), [Rh(C2H4)2Cl]2 (5 mol%), IMes (10 mol%), 2-aminopyridine (25 mol%), TsOH.H2O (10 mol%), H2O (50 mol%) in 0.4 mL of 1,4-dioxane at 140 °C for 48 h. Isolated yields for the 1-tetralone product were reported. The regioselective ratios (rr) of C−C activation were determined by 1H NMR using 1,1,2,2-tetrachloroethane as the internal standard. Enantiomeric ratios were determined by HPLC analysis using commercial chiral columns. Enantiospecificity (es) were calculated based on the er of 2a-2l.
To demonstrate the practicability of this strategy, gram-scale reactions were carried out (Scheme 2a). On a 10 mmol scale, the Pd-catalyzed asymmetric 1,4-addition gave 2a in 97% yield and 97.0:3.0 er. The following Rh-catalyzed C–C activation was also scalable even with a lower catalyst loading, while the regioselectivity was slightly decreased. In addition, the 1-tetralone product (3a) could be conveniently transformed to an interesting tetracycle (4a) in 96% yield through Fischer indole synthesis. Alternatively, it could be converted to a trisubstituted alkene (5a) via a palladium-catalyzed carbene coupling reaction with 4-bromotoluene through the formation of the corresponding N-tosylhydrazone (Scheme 2b).20
Scheme 2.

Gram-scale synthesis and synthetic applications
In summary, we have demonstrated a unique approach to access enantioenriched 1-tetralones with an all-carbon quaternary stereocenter that is remote from the carbonyl moiety. Through a two-step sequence of Pd-catalyzed asymmetric conjugate addition and Rh-catalyzed C−C activation, chiral 1-tetralones have been obtained in good overall yields and excellent enantioselectivity from readily available cyclopentenones and arylboronic acids. The scalability and chemoselectivity could make this method attractive for complex molecule synthesis. While the current scope is limited to 1-tetralone products, the strategy–that is forming a proximal stereocenter with established methods and then transporting it to a distal position–could have broad implications beyond this work.
Supplementary Material
Acknowledgments
This project was supported by NIGMS (2R01GM109054). S.O. acknowledged Ezoe Memorial Recruit Foundation for his pre-doctoral fellowship. Chiral Technologies is acknowledged for their generous donation of chiral HPLC columns. Dr. Si-Hua Hou is thanked for helpful discussion. Umicore AG & Co. KG is acknowledged for a generous donation of Rh salts. The article is dedicated to Professor Eiichi Nakamura on the occasion of his 70th birthday.
Biographies

Shusuke Ochi

Ying Xia

Guangbin Dong
Footnotes
Supporting Information is available on http://dx.doi.org/10.1246/bcsj.***.
References
- 1.a) Hong AY, Stoltz BM, Eur. J. Org. Chem 2013, 2745. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Liu Y, Han S-J, Liu W-B, Stoltz BM, Acc. Chem. Res 2015, 48, 740. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Chen W, Zhang H, Sci China Chem 2016, 59, 1065. [Google Scholar]; d) Li C, Ragab SS, Liu G, Tang W, Nat. Prod. Rep 2020, 37, 276. [DOI] [PubMed] [Google Scholar]
- 2.a) Douglas CJ, Overman LE, Proc. Natl. Acad. Sci. U.S.A 2004, 101, 5363. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Quasdorf KW, Overman LE, Nature 2014. 516, 181. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Feng J, Holmes M, Krische MJ, Chem. Rev 2017, 117, 12564. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Trost BM, Schultz JE, Synthesis 2019, 51, 1. [Google Scholar]
- 3.a) Johansson CCC, Colacot TJ, Angew. Chem., Int. Ed 2010, 49, 676. [DOI] [PubMed] [Google Scholar]; b) Bellina F, Rossi R, Chem. Rev 2010, 110, 1082. [DOI] [PubMed] [Google Scholar]; Also see references 1b and 2c.
- 4.a) Hawner C, Alexakis A, Chem. Commun 2010, 46, 7295. [DOI] [PubMed] [Google Scholar]; b) Shockley SE, Holder JC, Stoltz BM, Org. Process Res. Dev 2015, 19, 974. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Heravi MM, Dehghani D, Zadsirjan V, Tetrahedron: Asymmetry 2016, 27, 513. [Google Scholar]
- 5.For examples on construction of all-carbon stereocenters at remote site, see:; a) Mei T-S, Patel HH, Sigman MS, Nature 2014, 508, 340. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Patel HH, Sigman MS, J. Am. Chem. Soc 2016, 138, 14226. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Xu Y, Qi X, Zheng P, Berti CC, Liu P, Dong G, Nature 2019, 567, 373. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Wei Q, Cai J, Hu X-D, Zhao J, Cong H, Zheng C, Liu W-B, ACS Catal. 2020, 10, 216. [Google Scholar]
- 6.For recent reviews on C−C activation of strained molecules, see:; a) Seiser T, Saget T, Tran DN, Cramer N, Angew. Chem., Int. Ed 2011, 50, 7740. [DOI] [PubMed] [Google Scholar]; b) Mack DJ, Njardarson JT, ACS Catal. 2013, 3, 272. [Google Scholar]; c) Chen P-H, Dong G, Chem.—Eur. J 2016, I, 18290. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Fumagalli G, Stanton S, Bower JF, Chem. Rev 2017, 117, 9404. [DOI] [PubMed] [Google Scholar]
- 7.For recent reviews on C−C activation of less-strained molecules, see:; a) Rybtchiski B, Milstein D, Angew. Chem., Int. Ed 1999, 38, 870. [DOI] [PubMed] [Google Scholar]; b) Chen F, Wang T, Jiao N, Chem. Rev 2014, 114, 8613. [DOI] [PubMed] [Google Scholar]; c) Kim D-S, Park W-J, Jun C-H, Chem. Rev 2017, 117, 8977. [DOI] [PubMed] [Google Scholar]; d) Song F, Gou T, Wang B-Q, Shi Z-J, Chem. Soc. Rev 2018, 47, 7078. [DOI] [PubMed] [Google Scholar]
- 8.a) Nakamoto H, Ishizuka N, Takeda S, Yoshimura Y, Eur. Patent EP0384917, 1990.; b) Bajpai VK, Kang SC, Bangladesh J Pharmacol. 2014, 9, 312. [Google Scholar]; c) Hu HJ, Zhou Y, Han ZZ, Shi YH, Zhang SS, Wang ZT, Yang L, J. Nat. Prod 2018, 81, 1508. [DOI] [PubMed] [Google Scholar]; d) Li R, Liu Z, Chen L, Pan J, Lin K, Zhou W Beilstein J. Org. Chem 2018, 14, 2340. [DOI] [PMC free article] [PubMed] [Google Scholar]; e) Hamulić D, Stadler M, Hering S, Padrón JM, Bassett R, Rivas F, Loza-Mejía MA, Dea-Ayuela MA, González-Cardenete MA, J. Nat. Prod 2019, 82, 823. [DOI] [PubMed] [Google Scholar]
- 9.a) Xia Y, Lu G, Liu P, Dong G, Nature 2016, 539, 546. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Xia Y, Wang J, Dong G, Angew. Chem., Int. Ed 2017, 56, 2376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hou S-H, Prichina AY, Zhang M, Dong G, Angew. Chem., Int. Ed 2020, 59, 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hayashi T, Yamasaki K, Chem. Rev 2003, 103, 2829. [DOI] [PubMed] [Google Scholar]
- 12.Lin S, Lu X, Org. Lett 2010, 12, 2536. [DOI] [PubMed] [Google Scholar]
- 13.a) Kikushima K, Holder JC, Gatti M, Stoltz BM, J. Am. Chem. Soc 2011, 133, 6902. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Holder JC, Marziale AN, Gatti M, Mao B, Stoltz BM, Chem.—Eur. J 2012, 19, 74. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Holder JC, Zou L, Marziale AN, Liu P, Lan Y, Gatti M, Kikushima K, Houk KN, Stoltz BM, J. Am. Chem. Soc 2013, 135, 14996. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Holder JC, Goodman ED, Kikushima K, Gatti M, Marziale AN, Stoltz BM, Tetrahedron 2015, 71, 5781. [DOI] [PMC free article] [PubMed] [Google Scholar]; e) Boeser CL, Holder JC, Taylor BLH, Houk KN, Stoltz BM, Zare RZ, Chem. Sci 2015, 6, 1917. [DOI] [PMC free article] [PubMed] [Google Scholar]; f) Holder JC, Shockley SE, Wiesenfeldt MP, Shimizu H, Stoltz BM, Org. Synth 2015, 92, 247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.a) Gottumukkala AL, Matcha K, Lutz M, de Vries JD, Minnaard AJ, Chem.—Eur. J 2012, 18, 6907. [DOI] [PubMed] [Google Scholar]; b) Buter J, Moezelaar R, Minnaard AJ, Org. Biomol. Chem 2014, 12, 5883. [DOI] [PubMed] [Google Scholar]
- 15.de Gracia Retamosa M, Álvarez-Casao Y, Matador E, Gómez Á, Monge D, Fernández R, Lassaletta JM, Adv. Synth. Catal 2019, 361, 176. [Google Scholar]
- 16.a) Zeeland RV, Stanley LM, ACS Catal. 2015, 5, 5203. [Google Scholar]; b) Kadam AA, Ellern A, Stanley LM, Org. Lett 2017, 19, 4062. [DOI] [PubMed] [Google Scholar]
- 17.3-Methyl-1-cyclopentenone cannot be used as a substrate with this strategy as it will not generate a stereocenter in the 1-tetralone product.
- 18. 2-Methylphenylboronic acid gave the adduct in < 20% yield with 1a under the identical condition to 2i. Decreased reactivity by ortho-substituents in the Pd-catalyzed asymmetric 1,4-addition were also reported in refs 13d, 14b, 15 and 16b.
- 19.Jung ME, Piizzi G, Chem. Rev 2005, 105, 1735. [DOI] [PubMed] [Google Scholar]
- 20.Xia Y, Qiu D, Wang J, Chem. Rev 2017, 117, 13810. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
